Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biat Group is a global biotechnology corporate group with subsidiaries specializing in zebrafish model-based toxicity/efficacy testing, proprietary intein technologies enabling gene therapy, immunotherapy, diagnostics, smart vaccines, RNA/DNA vaccine delivery systems, and protein purification solutions. The group's assets support both preclinical research services and industrial biotech product innovation[1][2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biat Group.